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Background: The complex disease of diabetes mellitus type 2 (T2DM) requires a high standard of quality of care.
Clinical practice guidelines define norms for diabetes care that ensure regular monitoring of T2DM patients, including
annual diagnostic tests. This study aims to quantify guideline adherence in Dutch general practices providing care to
T2DM patients and explores the association between guideline adherence and patients’ health outcomes.
Methods: In this cross-sectional study, we studied 363 T2DM patients in 32 general practices in 2011 and 2012.
Guideline adherence was measured by comparing structure and process indicators of care with recommendations
in the national diabetes care guideline. Health outcomes included biomedical measures and health behaviours.
Data was extracted from medical records. The association between guideline adherence and health outcomes was
analysed using hierarchical linear and logistic regression models.
Results: Guideline adherence varied between different recommendations. For example 53% of the practices had a
system for collecting patient experience feedback, while 97% had a policy for no-show patients. With regard to
process indicators of care, guideline adherence was below 50% for foot, eye and urine albumin examination and
high (>85%) for blood pressure, HbA1c and smoking behaviour assessment. Although guideline adherence varied
considerably between practices, after adjusting for patient characteristics we found guideline adherence not to be
associated with patients’ health outcomes.
Conclusions: Guideline adherence in Dutch general practices offering diabetes care was not optimal. Despite
considerable variations between general practices, we found no clear relationship between guideline adherence
and health outcomes. More research is needed to better understand the relationship between guideline
adherence and health outcomes, specifically for guidelines that are based on limited scientific evidence.
Keywords: Integrated care, Diabetes mellitus, Guideline adherence, Measurement of quality of care, Health
outcomesBackground
The complex disease of diabetes mellitus type 2 (T2DM)
requires a high standard of quality of care. The objec-
tives of treatment are controlling glycaemia, blood pres-
sure and blood lipid levels, improving lifestyle behaviour
and reducing tobacco use [1]. These objectives are ex-
pected to lead to a reduction in the burden of diabetes
and its complications. However, optimal treatment is not* Correspondence: s.oudewesselink@erasmusmc.nl
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article, unless otherwise stated.consistently implemented in clinical practice [2], one pos-
sible reason being inadequate adherence to clinical prac-
tice guidelines. Such guidelines may well help to improve
care, because they specify optimal care for care providers
and allow adherence to be monitored. Additional benefits
from following guidelines include improving health out-
comes, empowering patients, improving the quality of
clinical decisions, supporting quality improvement activ-
ities, increasing efficiency, and identifying areas where
there is insufficient evidence to support optimal care [3].
A national guideline on integrated diabetes care in the
Netherlands was formulated in 2007 [4]. It was developedCentral. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
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contributions from patients, practitioners and scientists.
As well as aiming to improve outcomes of care and to re-
duce the costs of managing T2DM, it also contains general
information about diabetes and recommendations on the
content, organisation and quality of diabetes care. With a
focus on integrated care, it contains instructions for the
structure of diabetes care and recommends specific assess-
ments and examinations. Because the guideline is only
based on consensus, most of its recommendations are not
evidence based. The consensus is based on opinions, on
other guidelines and on legislation.
The extent to which care professionals adhere to the
broad scope of this guideline is unknown. Previous stud-
ies have shown that the proportion of patients in which
practices conducted annual measurements of HbA1c,
blood pressure, LDL-cholesterol and urine albumin
ranges between 49% and 86% [2]. However, for other
quality-of-care indicators adherence is unknown.
Although following guidelines should theoretically im-
prove health outcomes, evidence from empirical studies
is mixed [5-7]. Previous studies relating guideline adher-
ence to health outcomes have only tested a few specific
elements of diabetes guidelines and do not provide con-
clusions about the overall effect of guideline adherence
in T2DM patients. We therefore studied a range of
structure and process indicators of care that are men-
tioned in the guideline.
This study aims to quantify guideline adherence in
general practices providing care to T2DM patients in
the Netherlands and explores the association between
guideline adherence and patients’ health outcomes.
Methods
Study population
In the Netherlands, care groups are organisations that
provide integrated diabetes care to patients in primary
care (Additional file 1: Box S1). These groups consist of
3 to 250 general practitioners, which are funded under a
bundled payment system [8]. Care groups are similar to
accountable care organizations [9]. From the approxi-
mately 100 care groups in the Netherlands, we randomly
selected 33. Of these, 18 care groups participated and 15 re-
fused participation (response rate 55%) (Additional file 1:
Figure S1). The reasons given for refusal were as follows:
too busy with providing care to patients (n = 4), no com-
pensation for time loss due to research (n = 2), do not agree
with purpose of research (n = 1), currently involved in other
research (n = 1) and unknown (n = 7).
Each participating care group selected one or two
practices to participate in this study, based on their
availability to participate in research. In total 32 prac-
tices participated in our study, together employing 32
practice nurses. Practice nurses either have a registerednursing degree or are practice assistants who have
followed a two-year practice nursing degree.
Patient and practice data were collected from the gen-
eral practices cross-sectionally between June 2011 and
July 2012. For each practice, based on the schedule of last
month, we randomly selected between 7 and 18 patients
who had had a check-up in the last month. For these pa-
tients, data from the medical records was extracted by the
practice nurses, together with the research assistants. In
addition, the practice nurses were also asked to complete
a questionnaire about guideline adherence.
No-one (care groups, practices or patients) received fi-
nancial compensation for participating in this study. The
local ethics committee of Erasmus University Medical
Centre waived ethical approval for this particular ana-
lysis. A written informed consent was obtained from all
participating practice nurses.
Study variables and definitions
The main outcome parameters of the study were guide-
line adherence in the practices and health outcomes in
the patients. We also collected data on patient character-
istics for use in the statistical analysis.
All variables were obtained from patient files and the
most recent measurements were used. Health outcomes
were BMI, systolic blood pressure, HbA1c, LDL choles-
terol, urine albumin, glomerular filtration rate (GFR)
and smoking behaviour. BMI (kg/m2), blood pressure
(mmHg) and smoking behaviour (yes/no) were assessed
in general practices and documented in patient files.
Glucose (mmol/L), HbA1c (mmol/mol), LDL cholesterol
(mmol/L), urine albumin (mg/L) and GFR (ml/min) were
assessed in cooperation with diagnostic centres and docu-
mented in patient files. Measurements from before 2009
were not used, because these health outcomes were
regarded as potentially outdated.
Guideline adherence was assessed by considering both
structure and process indicators of care. Structure indi-
cators, defined at practice level, were assessed by asking
practice nurses whether they: have a system for collecting
patient experience feedback, have regulations on access to
patient files, have quarterly multidisciplinary meetings,
have policies for checking medical equipment, have re-
ceived training in self-management and have policies for
no-show patients. Each question was given a numerical
score of 1 (yes) or 0 (no) and these numbers were added
to compose an aggregated score for structure indicators of
care at each practice, ranging from 0 for the lowest to 6
for the highest quality of care in terms of structures
(Table 1).
We defined process indicators at the patient level as be-
ing the previously mentioned annually measured health
outcomes and obtained data from the patient records. A
measurement was considered to be annual if the time
Table 1 Construction of guideline adherence scores,
divided into structures and process indicators of care
Structure score1 Points
System for collecting patient experience feedback 0 or 1
Regulations on access to patient files 0 or 1
Quarterly multidisciplinary meetings 0 or 1
Policies for checking medical equipment 0 or 1
Practice nurse trained in self-management 0 or 1
Policy for no-show patients 0 or 1
Score range 0-6
Process score2
Annual assessment of BMI 0-1
Annual assessment of blood pressure 0-1
Annual assessment of HbA1c 0-1
Annual assessment of LDL cholesterol 0-1
Annual assessment of urine albumin 0-1
Annual assessment of GFR 0-1
Annual assessment of smoking behavior 0-1
Annual foot examination 0-1
Annual eye examination 0-1
Score range 0-9
1Structure score, composite score of different structure indicators of care,
scoring: present = 1 point, absent = 0 points.
2Process score, composite score of different process indicators of care, the
proportion of patients per practice that were tested annually for each
indicator, range between 0 and 1.
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For each practice we then calculated the proportion of pa-
tients in whom annual measurements had been done, as
recommended by the guidelines. Once more an aggre-
gated score for processes of care at each practice was com-
posed, ranging from 0 for the lowest to 9 for the highest
quality of care in terms of processes (Table 1).
For each practice, we analysed guideline adherence ac-
cording to structure and process indicators of care.
Each structure indicator was coded as yes/no per prac-
tice, resulting in an aggregated percentage of guideline
adherence in all practices for each structure indicator.
For process indicators we also calculated an aggregated
percentage of patients per practice, resulting in an aver-
age guideline adherence across all practices for each
process indicator.
The patient characteristics consisted of demographic
factors and clinical factors. Demographic factors were age
at data collection (years), sex and an indicator of socio-
economic status (SES). Clinical factors were years since
diagnosis of T2DM (between diagnosis and the moment
of data collection) and comorbidities (defined using ICPC
codes) [10]. Comorbidities unrelated to T2DM were based
on general national guidelines [11] while comorbidities re-
lated to T2DM were derived from the National DiabetesGuideline (Additional file 1: Table S2) [4]. All patient char-
acteristics, except SES, were collected from patient files.
The SES was based on the neighbourhood (postal code)
of the general practice where the patient was treated.
This score was obtained from a government agency
(Netherlands Institute for Social Research) [12] and
ranges from -10 to +10. A higher score represents a
higher SES.
Statistical analysis
Guideline adherence was described at the practice level.
Patient characteristics and health outcomes were de-
scribed at both the patient and practice levels. The asso-
ciations were evaluated using hierarchical linear and
logistic regression models. In hierarchical models, the
clustering of patients within practices is taken into ac-
count [13].
Variation in guideline adherence between practices
was described per indicator with interquartile ranges
(IQR). The statistical significance of the variation be-
tween practices was tested in hierarchical regression
models with the structure or process indicator of care as
the dependent variable and a random intercept for the
practices. Variation in health outcomes between prac-
tices was analysed with hierarchical regression models
with the health outcome as the dependent variable and a
random intercept for the practices.
Finally, to analyse the association between guideline
adherence and health outcomes, adjusted for patient
characteristics, we added to the model the aggregated
score for structures or processes per practice as inde-
pendent variable. The different health outcomes served
as dependent variable. General practice was included in
the model as a random intercept. Each health outcome
was analysed separately and patients with missing out-
comes (9% at most) were excluded from the analysis.
Guideline adherence was analysed at practice level to
avoid confounding by indication. Confounding by indi-
cation is a common problem in observational studies,
where treatment is usually only given to patients who re-
quire it [14]. Without adjustment on practice level in the
data analysis, appropriate treatment will always be re-
lated to poor health outcome, particularly in individual-
level studies. By analysing adherence at the practice
level, we can test whether practices with generally good
guideline adherence have good outcomes.
The one covariate for which values were missing in
about 50% of cases, namely year since diagnosis, was im-
puted with linear regression analysis based on seven co-
variates (sex, age, related and unrelated comorbidities,
SES, structure and process quality scores).
From the regression models we derived beta scores (in
the case of a continuous outcome) or odds ratios (in
case of a binary outcome) and 95% confidence intervals.
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SAS version 9.3 (PROC MIXED and PROC GLIMMIX)
(SAS Institute Inc., Cary, NC) and for other analyses SPSS
version 21.0 (IBM Inc., Somers, NY).
Results
Thirty-two general practices participated in the study.
We included between 7 and 18 patients per practice,
resulting in 363 patients in total. Guideline adherence
was assessed according to structure and process indica-
tors of care (Table 2). Structure scores are expressed as
the proportion of practices that answered positively to
each of the questions about guideline adherence. For ex-
ample, only 53% of practices reported that they system-
atically collect patient experience feedback. Adherence
was also below 70% for regulations on access to patient
files (63%) and for conducting quarterly multidisciplin-
ary meetings (66%). For other structural aspects, guide-
line adherence was better: almost all practices had a
policy for no-show patients (97%), a practice nurse
trained in self-management (94%) and policies for check-
ing medical equipment (91%). Overall, there was limited
variation between practices for guideline adherences ac-
cording to structure indicators of care; the IQR of the
total structure score was 4 to 5 (p = 1.00).
Guideline adherence measured according to process
indicators of care, also shown in Table 2, is expressed asTable 2 Description of mean scores for guideline adherence i
Structure score Guideline adherenc
System for collecting patient experience feedback 0.53
Regulations on access to patient files 0.63
Quarterly multidisciplinary meetings 0.66
Policies for checking medical equipment 0.91
Practice nurse trained in self-management 0.94
Policy for no-show patients 0.97
Total structures of care score (points) mean: 4.7 (scale 0-6)
Process score Guideline adherenc
Annual assessment of BMI 0.70
Annual assessment of blood pressure 0.97
Annual assessment of HbA1c 0.91
Annual assessment of LDL cholesterol 0.59
Annual assessment of urine albumin 0.49
Annual assessment of GFR 0.65
Annual assessment of smoking behavior 0.89
Annual foot examination 0.33
Annual eye examination 0.28
Total processes of care score (points) mean: 5.9 (scale 0-9)
*Differences between practices, tested in hierarchical regression model, without oth
IQR, interquartile range; BMI, body mass index; HbA1c, glycosylated haemoglobin; LDLthe proportion of patients receiving treatment according
to the guideline. For example, 70% of patients were
assessed annually for BMI and the IQR for the percent-
ages per practice was 41% to 100%. Guideline adherence
was below 50% for the assessment of urine albumin
(49%) and for the examination of the feet (33%) and eyes
(28%). However, guideline adherence was above 85% for
blood pressure (97%), HbA1c (90%) and smoking behaviour
(89%). The scores for the process indicators varied largely
between practices: the IQR was often more than 30%. The
IQR of the total process score was 5.3-6.6 (p = 1.00).
Table 3 shows the patient characteristics and health
outcomes. Median age of the 363 patients was 65 years
and about half were males (49%). Median HbA1c was
50 mmol/mol and median GFR was 68 ml/min. The per-
centage of missing health outcomes was low; less than
7%. The study population was comparable to those of
previous studies [7,15].
Several patient characteristics varied significantly be-
tween practices. For example mean age per practice had
an IQR of 63 to 70 years (p = 0.02). Health outcomes
also differed across practices. For example, the IQR of
HbA1c was 48 to 55 mmol/mol (p = 0.01) and for GFR
IQR was 63 to 86 ml/min (p = 0.00) (Table 3). The pa-
tient characteristics were not associated with guideline
adherence, indicating that adherence was not better or
worse in specific patient groups (data not shown).ndicators in general practices (n = 32)
e (proportion of practices) IQR p-value*
4 - 5 1.00
e (proportion of patients per practice) IQR p-value*
0.41 - 1.00 0.00
0.92 - 1.00 1.00
0.85 - 1.00 0.00
0.42 - 0.76 0.00
0.35 - 0.66 0.01
0.48 - 0.78 0.00
0.86 - 0.98 0.00
0.12 - 0.49 0.00
0.10 - 0.43 0.03
5.3 - 6.6 1.00
er independent factors.
cholesterol, low-density lipoprotein cholesterol; GFR, glomerular filtration rate.
Table 3 Description of patient characteristics and unadjusted health outcomes for all patients (n = 363) and at practice
level (n = 32)
Patients Practices
n Median IQR Median IQR p-value*
Patient characteristics
Age (years) 363 65 58 - 74 66 63 - 70 0.02
Sex (% males) 363 49% 52% 43 - 58% 1.00
Years since diagnosis 175 6 3 - 9 7 5 - 9 0.04
Number of related comorbidities1 363 1 0 - 1 0.6 0.4 - 0.9 0.00
Number of unrelated comorbidities2 363 0 0 - 1 0.4 0.2 - 0.5 0.02
SES indicator3 Low 363 46% 44%
Middle 34% 34%
High 20% 22%
Health outcomes
BMI (kg/m2)4 343 29 26 - 33 29 29 - 31 0.10
Systolic blood pressure (mmHg)5 363 135 123 - 145 134 131 - 140 0.02
HbA1C (mmol/mol)6 361 50 45 - 56 51 48 - 55 0.01
LDL cholesterol (mmol/L)7 358 2.3 1.9 - 2.9 2.5 2.2 - 2.6 1.00
Urine albumin (mg/L)8 341 6 3 - 13 11 6 - 32 0.06
GFR (ml/min)9 356 68 60 - 89 74 63 - 86 0.00
Smoking (% smokers) 353 18% 17% 11 - 25% 1.00
*Differences between practices, tested in hierarchical regression model, without other independent factors.
ICC of patient characteristics, range: 0.07-0.16. ICC of outcomes, range: 0.04-0.25.
1in total 12 ICPC codes.
2in total 63 ICPC codes.
3Score calculated nationally based on the postal code of the general practice where the patient was treated, low = lowest tertile, middle =middle tertile,
high = highest tertile.
4Body mass index (range in this study: 19-53).
5Systolic blood pressure (range in this study: 95-197).
6Glycosylated haemoglobin (range in this study: 32-99).
7Low-density lipoprotein cholesterol (range in this study: 0.5-5.9).
8Urine albumin (range in this study: 0-1023).
9Glomerular filtration rate, higher is better (range in this study: 13-178).
IQR, interquartile range.
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using regression models, we found several associations
between patient characteristics and health outcomes
(Additional file 1: Table S1). For example, HbA1c was
higher in patients who had a longer duration of diabetes
(95% CI 0.0-0.4) or a higher number of related comor-
bidities (95% CI 0.2-3.2). Low GFR was associated with a
higher age, meaning that kidney function worsens with
older age (95% CI -0.9;-0.6).
Finally, we explored the associations between guideline
adherence and health outcomes (Table 4). We found no
clear relationships between guideline adherence and the
health outcomes under study. The estimated effects point
to both positive and negative associations between guide-
line adherence and health outcomes. Only systolic blood
pressure was positively related to both structure and
process indicators of care, but this relationship was not
statistically significant.Discussion
Summary of main findings
Guideline adherence varied between different recom-
mendations. For example 53% of the practices had a sys-
tem for collecting patient experience feedback, while
97% had a policy for no-show patients. With regard to
process indicators of care, guideline adherence was below
50% for foot, eye and urine albumin examination and high
(>85%) for blood pressure, HbA1c and smoking behaviour
assessment. Although guideline adherence varied consider-
ably between practices, after adjusting for patient charac-
teristics we found guideline adherence not to be associated
with patients’ health outcomes.
Strengths and limitations
The study has several strengths and limitations. One
strength is that we retrieved actual guideline adherence
with regard to several indicators at the patient level,
Table 4 Associations between guideline adherence and
health outcomes, analysed with hierarchical linear and
logistic regression models (n = 363)
β (95% CI)
BMI (n = 343)
Structure −0.03 (-0.88;0.82)
Process 0.51 (-0.24;1.26)
Systolic blood pressure (n = 363)
Structure 1.70 (-1.08;4.47)
Process 1.97 (-0.46;4.39)
HbA1C (n = 361)
Structure 0.75 (-1.01;2.50)
Process −0.64 (-2.19;0.90)
LDL cholesterol (n = 358)
Structure −0.017 (-0.120;0.086)
Process −0.013 (-0.107;0.080)
Urine albumin (n = 341)
Structure −1.58 (-16.44;13.29)
Process 3.32 (-10.20;16.84)
GFR (n = 356)
Structure 4.54 (-0.39;9.47)
Process −2.53 (-6.99;1.94)
Smoking* (n = 353)
Structure (OR) 1.13 (0.80;1.60)
Process (OR) 0.93 (0.68;1.28)
*Analysed with logistic regression: estimated odds ratio (OR)
(smoker = 1, non-smoker = 0).
CI, confidence interval; BMI, Body Mass Index (kg/m2); Systolic blood pressure
(mmHg); HbA1c, Glycosylated haemoglobin (mmol/mol); LDL cholesterol,
Low-density lipoprotein cholesterol (mmol/L); Urine in albumin (mg/L); GFR,
Glomerular Filtration Rate (higher is better) (ml/min).
Structure: structures of care score per practice, see Table 1.
Process: processes of care score per practice, see Table 1.
All models control for age, sex, years since diagnosis, number of related and
unrelated comorbidities and social economic status.
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practice level. A second strength is the method of data
collection, as the research assistant collected the data
from the patient files together with the practice nurse,
our data were reliable with only a low number of miss-
ing values.
A limitation of this study was the substantial number
of care groups that refused to participate. Of the 33 care
groups that were approached, 15 refused to participate.
Since it is possible that refusal is associated with poor
guideline adherence, actual guideline adherence may be
worse than that found in this study.
Another limitation of this study was the cross-sectional
design, with guideline adherence and health outcomes be-
ing measured at the same time. As in practice it will
take some time before better guideline adherence re-
sults in improved health outcomes, we have to assumethat differences in guideline adherence between prac-
tices are relatively constant over time. Violation of this
assumption, i.e. rapid changes in guideline adherence
over time in individual practices, may have led to an
underestimation of associations between guideline ad-
herence and health outcomes.
Two arbitrary choices were made during data analysis,
that may also have affected our results: firstly, we con-
structed the guideline adherence scores based on a com-
parable scientific paper [5], and secondly, for the process
indicators we used the number of days between check-
ups to determine whether or not there was adherence to
the guideline. In order to assess the robustness of the
different choices made regarding these two issues, we
performed a series of sensitivity analyses in which the
scoring was adjusted as follows: (1) putting double
weight on multidisciplinary meetings, policy for no-show
patients and training in self-management, as these are
directly related to patient care; (2) putting double weight
on all indicators with the exception of the foot and eye
examination; (3) giving three points instead of one for an-
nual assessment of the specific outcome under study; (4)
increasing the number of days between assessments con-
sidered to be as adherent from 366 to 400, 450 or 500 days.
All four sensitivity analyses yielded the same results as
those found in the main analyses (data not shown).
Finally, when comparing our results with those of
others, it should be taken into account that hard mor-
bidity and mortality outcomes are frequently considered
to be more important and more relevant to patients than
the health outcomes used in this study. However, these
endpoints, that include cardiovascular events and death,
occur too infrequently in a general practice population
[16] to be used as an outcome in our study.
A further consideration is that while the general prac-
tices were selected by the care groups, we do not expect
selection bias to have occurred as the care groups were
not aware of the aim of this study in advance. Further-
more, patients were selected at random.
Interpretation
Guideline adherence was suboptimal for several struc-
ture and process indicators of care. With regard to
structure, a system for collecting patient experience
feedback had not yet been widely implemented, although
some practices had started a first investigation. Our find-
ing that regulations on access to patient files also scored
below 70% was likely due to the fact that such agree-
ments often do not cover the care group as a whole, as
stated by the practices nurses. Practices nurses reported
also that quarterly multidisciplinary meetings did not
cover all care providers of the care groups and that these
meetings sometimes did not include discussion of indi-
vidual patients.
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ited for half of the process indicators of care, with three
scoring below 50%: assessment of urine albumin and
examination of the eyes and feet. Eye examinations were
always conducted outside the general practice and the
practice did not always receive the patient’s report after
these examinations, as stated by practice nurses. In con-
trast, foot examinations were performed in the general
practice, but often less than once a year. The fact that
assessment of urine albumin scored lower than other la-
boratory assessments may well be due to patients not al-
ways supplying urine samples to the laboratory when
necessary.
Since many quality indicators scored below 70% adher-
ence, we conclude that guideline adherence is suboptimal
in general practices offering diabetes care. Not only are our
results in line with those of previous research [2], but they
also give insight into guideline adherence with respect to
structure indicators of care. The fact that we found large
differences in guideline adherence between practices is also
consistent with previous studies in diabetes care [17].
If we assume that guidelines describe optimal and
evidence-based care, then variation in guideline adher-
ence is undesirable. However, we found no relationship
between guideline adherence and health outcomes. This
finding is in line with those of other studies. For ex-
ample, Ackerman et al found that in diabetes patients
improvements in processes of diabetes care were not as-
sociated with improvements in health outcomes [18].
Another study showed that improved processes of care
were associated with an improved mental health score,
but not with a physical health score [5]. A systematic re-
view also concluded that structure and process indica-
tors of diabetes care are largely unrelated to surrogate
and hard outcomes [19]. While these previous studies
tested just a few specific elements of diabetes guidelines,
our results expand on these previous results and suggest
that guideline adherence in general is not associated
with health outcomes.
The guideline that we studied is not completely evidence
based. While it is comparable to the NICE diabetes guide-
lines [20], not every single element of the guideline has
been underpinned with evidence [21]. This absence of evi-
dence underlying some aspects of the guideline might be
the explanation for the findings in our study – and in most
previous studies – that adherence to elements of diabetes
guidelines appears to have no effect on health outcomes.
This is supported by the fact that, in other disease fields
where the guidelines are more evidence-based, an associ-
ation between adherence and health outcomes has been
found [22-24]. In the case of T2DM, the lack of evidence
for single elements of the diabetes guideline is at least
partly due to the heterogeneity of the patient population,
which implies that not all guideline recommendationsapply to all patients. Additionally, while most recommen-
dations concern the frequency with which a measurement
should be done, e.g. measuring albumin once a year, they
do not specify the actions that should subsequently be
taken to improve outcome. However, the lack of a rela-
tionship between adherence and health outcomes might
also partly be explained by the degree of self-management
in diabetes: because it is a lifestyle-related disease, the role
played by the patient is central. If the patient does not
adapt his or her lifestyle to the disease, then his or her
health will not improve [25]. Nevertheless, the lack of evi-
dence underpinning clinical practice guidelines is a com-
mon problem in many disease fields [26] and cannot be
ruled out as an explanation for our results.
The weak scientific evidence underpinning the guideline
might also explain the relatively poor adherence: previous
research has shown that lack of familiarity and lack of out-
come expectancy can sometimes be barriers to guideline
adherence [27]. Another possible explanation for our re-
sults is that Dutch general practices might use alternative
guidelines [28]. Nevertheless, as the guideline we studies is
the only guideline for integrated diabetes care in the
Netherlands, it was this guideline that the Dutch Health-
care Inspectorate used to evaluate integrated diabetes care
in 2011 [29]. The Dutch Diabetes Federation, who devel-
oped the guideline, represents a broad spectrum of stake-
holders and the guideline therefore is acknowledged by all
professions involved in diabetes treatment.
Conclusion
In conclusion, guideline adherence in Dutch general
practices offering diabetes care was not optimal. Despite
considerable variations between general practices, we
found no clear relationship between guideline adherence
and health outcomes. For clinical practice, policy making
and supervision it is important to consider the large
variation in guideline adherence. While quality improve-
ment initiatives might reduce the observed variation, our
study suggests that better guideline adherence will not
automatically lead to better health outcomes.
More research is needed to better understand the rela-
tionship between guideline adherence and health out-
comes, specifically for guidelines that are based on
limited scientific evidence.
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